Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults

NCT ID: NCT02466945

Last Updated: 2015-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this clinical trial is to evaluate the tolerance and efficacy of a dental gel in patients with dentinal hypersensitivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this clinical trial is to evaluate the tolerance and efficacy of dental gel V063B-DP3003 in patients with dentinal hypersensitivity, under normal conditions of use, under dentist control.

The primary objective of this study is to evaluate the global oral and dental tolerance of the studied product after 28 days of use.

Some efficacy objectives have been added to observe the efficacy of the dental gel. The dentinal hypersensitivity will be evaluated by the investigator with a thermal stimulus on two sensitive teeth selected by the investigator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentinal Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

V063B-DP3003

all patients will received the study product (V063B-DP3003)

Group Type OTHER

V063B-DP3003

Intervention Type DEVICE

The medical device V063B-DP3003 has been developed to relieve and decrease dentinal hypersensitivity in patients by creating a film around the sensitive tooth in order to prevent pain. Application modalities: apply a pea size amount of product (around 0.5g) onto each of the sensitive teeth, 3 times a day, by gentle massage with clean finger after each brushing of teeth. Do not rinse

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

V063B-DP3003

The medical device V063B-DP3003 has been developed to relieve and decrease dentinal hypersensitivity in patients by creating a film around the sensitive tooth in order to prevent pain. Application modalities: apply a pea size amount of product (around 0.5g) onto each of the sensitive teeth, 3 times a day, by gentle massage with clean finger after each brushing of teeth. Do not rinse

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female
* Aged between18 and 70 years included
* Having signed his/her written informed consent,
* If it is a woman of childbearing potential :

Must have been using an effective method of contraception Negative Urine pregnancy test at inclusion,

* Subject who can be reached in case of emergency,
* Subject willing to be compliant to the protocol,
* Subject able to fill out the daily log and the questionnaire.
* Subject with at least 20 natural teeth (especially on the studied teeth),
* Subject with an healthy gum status according to the investigator,
* Subject with a mild to moderate dentinal hypersensitivity on at least 2 hypersensitive non adjacent teeth: with a Schiff cold air index from 1 to 2
* Subjects who show a response typical of sensitivity to the cold air blast at visit 1.

Exclusion Criteria

* Subject participating to any other biomedical research projects,
* For women : Pregnant or breastfeeding,
* Has forfeited his/her freedom by administrative or legal award or is under guardianship,
* Subject who, in the judgement of the investigator, is not likely to be compliant during the study,
* Subject unable to understand the information given (for linguistic or psychiatric reasons) and to give his/her consent in writing,
* Subject having dental braces
* Subject having immune system disorder,
* Subject having asthma,
* Subject having a disease liable to interfere with study data according to the investigator,
* Subject with teeth showing evidence of facets of attrition, premature contact, cracked enamel on the tooth to be studied and adjacent teeth,
* Subject with teeth showing evidence of irreversible pulpitis and active periodontal disease,
* Subject having caries on the tooth to be studied and adjacent teeth
* Subject having restauration of any type in the tooth to be studied,
* Subject having occlusal overload or occlusal adjustment recently made in the tooth to be studied,
* Subject with crowns , bridges in the area of sensitivity,
* Subject had undergone professional desensitizing therapy during the 3 previous months,
* Subject having a cutaneous-mucosal disease liable to interfere with study data according to the investigator, especially: herpes or medical history herpes, aphtous and medical history of aphtous, lichen planus, chronic lupus erythematosis,
* Subject having undergone surgery, chemical or physical treatment to the concerned study area in the last 3 months,
* Subject allergic or intolerant to one of the components of the study product,
* Subject having a background of intolerance or allergy to cosmetics, drugs or to other substances (fruits, lactose intolerant, nuts, etc.),
* Subject planning to have any dental care during the study.
* Subject having a treatment liable to interfere with study data (aspirin or derivatives, anti-inflammatories, and other analgesic, antibiotics, antihistaminics, corticoids, desensitizing substances, immunosuppressants, calcic inhibitors and anticonvulsants) 2 days before the inclusion visit,
* Subject having used of over the counter product for dentinal hypersensitivity within the previous six weeks,
* Subject being vaccinated (4 weeks prior) or expecting to be vaccinated during the study,
* Subject having modified his/her cosmetic habits (on the areas concerned by the study) during the last 2 weeks,
* Subject having applied any local product the day of the inclusion visit on the study area except the usual toothpaste
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pierre Fabre Dermo Cosmetique

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GARNER Kelly

Role: STUDY_CHAIR

Intertek Life Sciences

MACLURE Robert, MD

Role: PRINCIPAL_INVESTIGATOR

Intertek Life Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Intertek Life Sciences

Cheshire, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CHAMARD Christophe

Role: CONTACT

+33 5.62.48.85.66

BOUYSSOUNOUSE Aurore

Role: CONTACT

+33 5 62.48.85.67

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

GARNER Kelly

Role: primary

+44(0) 151 347 4810

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DP30032015003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dentinal Hypersensitivity Reduction
NCT06244290 COMPLETED PHASE3